Rare diseases
Investigational molecules
Locations
171 Oyster Point Boulevard Suite 300, 94080-2013, United States
Maze Therapeutics Inc. is focused on clinical research in APOL1 kidney disease, with attention to adult patients affected by proteinuria and related renal impairment.
The sponsor’s research activity is centered on therapeutic approaches for inherited and molecularly defined forms of kidney disease.
Maze Therapeutics Inc. runs clinical trials in conditions such as APOL1-mediated kidney disease, Phenylketonuria, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
